Michael Heltzen bought $11k of EXOZ
Chief Executive Officer at EXOZYMES INC.. 1,040 shares at an average of $10.22, traded Jul 2, 2025, filed Jul 2, 2025.
Score components
- +25RoleCEO
- 0Trade size$11k at market
- +3Relative to holdingsHoldings up 11%
- +8Price context50% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.2%, 3m +37.3%, 6m +6.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-017630, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 2, 2025 | POpen-market purchase Common Stock | +1,040 | $10.22 | $11k | 10,629 | Jul 2, 2025 |
Related signals
Other insiders at EXOZYMES INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | EXOZbuy EXOZYMES INC. | Michael Heltzen Chief Executive Officer | $6,405 855 shares | +6% | |
| 15Weak | EXOZsell EXOZYMES INC. | Tyler Paz Korman Chief Scientific Officer | $15k 1,500 shares | -0% | |
| 40Moderate | EXOZbuy EXOZYMES INC. | Michael Heltzen Chief Executive Officer | $20k 1,888 shares | +95% | |
| 33Weak | EXOZbuy EXOZYMES INC. | Michael Heltzen Chief Executive Officer | $22k 1,984 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.